Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 512902

Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR


Šamija, Ivan; Mateša, Neven; Lukač, Josip; Kusić, Zvonko
Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR // Diagnostic molecular pathology, 20 (2011), 4; 233-241 doi:10.1097/PDM.0b013e31821a59f1 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 512902 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR

Autori
Šamija, Ivan ; Mateša, Neven ; Lukač, Josip ; Kusić, Zvonko

Izvornik
Diagnostic molecular pathology (1052-9551) 20 (2011), 4; 233-241

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
thyroid neoplasms; thyroid nodule; biological tumor markers; fine-needle biopsy; reverse transcriptase polymerase chain reaction; galectin-3; CD44v6 antigen

Sažetak
The aim of the study was to determine diagnostic value of reverse transcriptase polymerase chain reaction (RT-PCR) analysis of galectin-3 and CD44v6 as markers for preoperative diagnosis of malignancy in lesions of the thyroid. RT-PCR analysis of galectin-3 and CD44v6 expression was performed on RNA isolated from fine-needle aspirates of thyroid lesions from 428 patients. The results were evaluated against the postoperative histopathological diagnosis or definitive cytological diagnosis in cases of nodular goiter and Hashimoto thyroiditis. 57 (13%) samples were inadequate for RT-PCR. Galectin-3 and CD44v6 were positive in 167 (45%) and 158 (43%) out of 371 adequate samples, respectively. Galectin-3 and CD44v6 were positive in 56 (86%) and 54 (83%) out of 65 papillary carcinomas, 16 (29%) and 18 (32%) out of 56 Hashimoto’s thyroiditis, 61 (34%) and 52 (29%) out of 181 nodular goiters, 23 (43%) and 23 (43%) out of 53 follicular adenomas, 3 (100%) and 3 (100%) out of 3 follicular carcinomas, and 8 (62%) and 8 (62%) out of 13 Hurthle cell adenomas, respectively. Specificity, sensitivity, positive, and negative predictive value in discriminating between malignant and benign thyroid nodules were 64, 87, 35, and 96% for galectin-3 ; 67, 84, 36, and 95% for CD44v6 ; and 79, 82, 47, and 95% for the analysis of both markers (considered positive only if both galectin-3 and CD44v6 were positive), respectively. Due to relatively low specificity, clinical value of galectin-3 and CD44v6 analysis by RT-PCR as a marker for preoperative diagnosis of malignancy in thyroid lesions is limited.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
134-1342428-2427 - Cirkulirajuće tumorske stanice u bolesnika sa solidnim tumorima (Kovačević, Dujo, MZOS ) ( CroRIS)
134-1342428-2430 - Karcinogeneza u štitnjači i gušavost u Hrvatskoj (Kusić, Zvonko, MZOS ) ( CroRIS)

Ustanove:
KBC "Sestre Milosrdnice"

Profili:

Avatar Url Neven Mateša (autor)

Avatar Url Ivan Šamija (autor)

Avatar Url Zvonko Kusić (autor)

Avatar Url Josip Lukač (autor)

Poveznice na cjeloviti tekst rada:

doi journals.lww.com

Citiraj ovu publikaciju:

Šamija, Ivan; Mateša, Neven; Lukač, Josip; Kusić, Zvonko
Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR // Diagnostic molecular pathology, 20 (2011), 4; 233-241 doi:10.1097/PDM.0b013e31821a59f1 (međunarodna recenzija, članak, znanstveni)
Šamija, I., Mateša, N., Lukač, J. & Kusić, Z. (2011) Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR. Diagnostic molecular pathology, 20 (4), 233-241 doi:10.1097/PDM.0b013e31821a59f1.
@article{article, author = {\v{S}amija, Ivan and Mate\v{s}a, Neven and Luka\v{c}, Josip and Kusi\'{c}, Zvonko}, year = {2011}, pages = {233-241}, DOI = {10.1097/PDM.0b013e31821a59f1}, keywords = {thyroid neoplasms, thyroid nodule, biological tumor markers, fine-needle biopsy, reverse transcriptase polymerase chain reaction, galectin-3, CD44v6 antigen}, journal = {Diagnostic molecular pathology}, doi = {10.1097/PDM.0b013e31821a59f1}, volume = {20}, number = {4}, issn = {1052-9551}, title = {Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR}, keyword = {thyroid neoplasms, thyroid nodule, biological tumor markers, fine-needle biopsy, reverse transcriptase polymerase chain reaction, galectin-3, CD44v6 antigen} }
@article{article, author = {\v{S}amija, Ivan and Mate\v{s}a, Neven and Luka\v{c}, Josip and Kusi\'{c}, Zvonko}, year = {2011}, pages = {233-241}, DOI = {10.1097/PDM.0b013e31821a59f1}, keywords = {thyroid neoplasms, thyroid nodule, biological tumor markers, fine-needle biopsy, reverse transcriptase polymerase chain reaction, galectin-3, CD44v6 antigen}, journal = {Diagnostic molecular pathology}, doi = {10.1097/PDM.0b013e31821a59f1}, volume = {20}, number = {4}, issn = {1052-9551}, title = {Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR}, keyword = {thyroid neoplasms, thyroid nodule, biological tumor markers, fine-needle biopsy, reverse transcriptase polymerase chain reaction, galectin-3, CD44v6 antigen} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • EMBASE (Excerpta Medica)
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font